Xeris Biopharma Holdings Overview
Xeris Biopharma Holdings Target Price
Analysts' 12-month price predictions for XERS.
Get informed when a big investor buys or sells
+ FollowShare Price
$6.88
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-12-08 | Barclays | $9 |  30.8% upside |  |
| 2025-10-29 | OppenheimerLeland Gershell | $18 | 161.6% upside | |
| 2025-03-07 | Piper Sandler | $4 |  41.9% downside | |
| 2024-11-11 | H.C. WainwrightOren Livnat | $6.6 | 4.1% downside | |
| 2024-10-23 | OppenheimerLeland Gershell | $5 | 27.3% downside | |
| 2024-05-10 | Piper SandlerDavid Amsellem | $3 | 56.4% downside | |
| 2022-04-28 | Craig-Hallum | $6.5 | 5.5% downside | |